Find Information About:

Drugs & Supplements

Get information and reviews on prescription drugs, over-the-counter medications, vitamins, and supplements. Search by name or medical condition.

Pill Identifier

Pill Identifier

Having trouble identifying your pills?

Enter the shape, color, or imprint of your prescription or OTC drug. Our pill identification tool will display pictures that you can compare to your pill.

Get Started
My Medicine

My Medicine

Save your medicine, check interactions, sign up for FDA alerts, create family profiles and more.

Get Started

WebMD Health Experts and Community

Talk to health experts and other people like you in WebMD's Communities. It's a safe forum where you can create or participate in support groups and discussions about health topics that interest you.

  • Second Opinion

    Second Opinion

    Read expert perspectives on popular health topics.

  • Community


    Connect with people like you, and get expert guidance on living a healthy life.

Got a health question? Get answers provided by leading organizations, doctors, and experts.

Get Answers

Sign up to receive WebMD's award-winning content delivered to your inbox.

Sign Up

Breast Cancer Health Center

Font Size

'Magic Bullet' Drug Delays Breast Cancer Worsening

T-DM1 Spares Women From Some, But Not All, Serious Side Effects

How T-DM1 Works continued...

But many metastatic breast cancers eventually become resistant to Herceptin. So researchers have been searching for new drugs that target HER2.

T-DM1 is such a drug. The "T" stands for trastuzumab, the scientific name for Herceptin. The DM1 is derived from an old chemotherapy drug called maytansine that was abandoned several decades ago when it was found to be too toxic for patients.

Because Herceptin only zeroes in on cancer cells that express HER2, DM1 is delivered only to those cells, Blackwell says.

"I think this will offer a very important therapeutic option for patients with HER2-positive metastatic breast cancer," she says. "I think it's the first of many antibody-drug [combinations] to follow that will link a potent anti-cancer agent to a targeted delivery system with an antibody."

About two dozen similar drugs, collectively known as antibody-drug conjugates, are in various stages of development, according to Louis M. Weiner, MD, director of the Lombardi Comprehensive Cancer Center at Georgetown University.

T-DM1 is a "magic bullet," Weiner says. He likens it to a Trojan horse that is welcomed into the cell while hiding something that is toxic to the cell.

The drug is made by Genentech, which funded the trial. The company plans to file for FDA approval later this year.

No cost has been set, but targeted cancer drugs often cost tens of thousands of dollars a month.

These findings were presented at a medical conference. They should be considered preliminary, as they have not yet undergone the "peer review" process, in which outside experts scrutinize the data prior to publication in a medical journal.

1 | 2

Today on WebMD

Breast Cancer Overview
From self-exams and biopsies to reconstruction, we’ve got you covered.
Dealing with breast cancer
Get answers to your questions.
woman having mammogram
Experts don’t agree on all fronts, but you can be your own advocate.
woman undergoing breast cancer test
Many women worry. But the truth? Most abnormalities aren’t breast cancer.
Breast Cancer Treatments Improving
Resolved To Quit Smoking
Woman getting mammogram
Screening Tests for Women
ovarian cancer overview slideshow
serious woman
what is your cancer risk
10 Ways to Revitalize Slideshow